Cargando…

Steroid Avoidance After Adult Living Donor Liver Transplant: A Cohort Analysis

Although steroid avoidance (SA) has been studied in deceased donor liver transplant, little is known about SA in living donor liver transplant (LDLT). We report the characteristics and outcomes, including the incidence of early acute rejection (AR) and complications of steroid use, in 2 cohorts of L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nunez, Miguel, Praglin, Claudia R., Torres, Ana M., Agudelo, Eliana Z., Braun, Hillary J., Huang, Chiung-Yu, Syed, Shareef, Roberts, John P., Roll, Garrett R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Liver Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212610/ https://www.ncbi.nlm.nih.gov/pubmed/37250489 http://dx.doi.org/10.1097/TXD.0000000000001488

Ejemplares similares

Avoiding ICU Admission by Using a Fast-Track Protocol Is Safe in Selected Adult-to-Adult Live Donor Liver Transplant Recipients
por: Echeverri, Juan, et al.
Publicado: (2017)

Donor BMI and Post–living Donor Liver Transplantation Outcomes: A Preliminary Report
por: Lin, Jessica S., et al.
Publicado: (2023)

The Kupffer Cell Number Affects the Outcome of Living Donor Liver Transplantation from Elderly Donors
por: Hidaka, Masaaki, et al.
Publicado: (2016)

A Donor Age-Based and Graft Volume–Based Analysis for Living Donor Liver Transplantation in Elderly Recipients
por: Imamura, Hajime, et al.
Publicado: (2017)

Transplant of SARS-CoV-2–infected Living Donor Liver: Case Report
por: Nguyen, Michelle C., et al.
Publicado: (2021)

Is a Preservation Solution for Living Donor Liver Transplantation Needed? Adding a New Chapter in LDLT!
por: Dogar, Abdul Wahab, et al.
Publicado: (2022)

Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience
por: Barbas, Andrew S., et al.
Publicado: (2017)

Living Donor Liver Transplantation Using a Liver Graft With Congenital Intrahepatic Portosystemic Shunt
por: Kamei, Hideya, et al.
Publicado: (2015)

Adult Living Donor Liver Transplantation for Patients With Portal Vein Thrombosis: A Single-center Experience
por: Miura, Kohei, et al.
Publicado: (2018)

Risk Factors for Intractable Ascites After Adult-to-Adult Living Donor Liver Transplantation Using Left Lobe
por: Matsudaira, Shinichi, et al.
Publicado: (2017)

Management of Ascites Following Deceased Donor Liver Transplantation: A Case Series
por: Al-Zoubi, Mohammad, et al.
Publicado: (2022)

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
por: Yamada, Yohei, et al.
Publicado: (2018)

Transplantation of a Liver Allograft From a Hepatitis C Virus Seropositive Donor With Previous Sustained Virologic Response to an Uninfected Recipient Suffering Steroid Refractory Acute Graft Rejection With No Evidence of HCV Transmission
por: Mitchell, Robert A., et al.
Publicado: (2018)

First Experience in Living Liver Donation From Donors With Sickle Cell Trait
por: Schulze, Maren, et al.
Publicado: (2022)

Outcomes of Living Donor Liver Transplantation Alone for Patients on Maintenance Renal Replacement Therapy in Japan: Results of a Nationwide Survey
por: Eguchi, Susumu, et al.
Publicado: (2016)

Effect of Fc-γ Receptor Polymorphism on Rituximab-Mediated B Cell Depletion in ABO-Incompatible Adult Living Donor Liver Transplantation
por: Sakai, Hiroshi, et al.
Publicado: (2017)

Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?
por: Tajima, Tetsuya, et al.
Publicado: (2019)

Effects of Adding Congested Segment IV to the Left Lateral Graft on Short-term Outcomes in Pediatric Living-donor Liver-transplant Recipients
por: Aoki, Hikaru, et al.
Publicado: (2023)

Kidney Donor Profile Index Is a Reliable Alternative to Liver Donor Risk Index in Quantifying Graft Quality in Liver Transplantation
por: Scheuermann, Uwe, et al.
Publicado: (2019)

Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center
por: Caicedo, Luis A., et al.
Publicado: (2017)

Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study
por: Ueda, Daisuke, et al.
Publicado: (2018)

A Formula to Calculate Standard Liver Volume Using Thoracoabdominal Circumference
por: Shaw, Brian I., et al.
Publicado: (2017)

Liver Transplantation With Grafts From Super Obese Donors
por: Vargas, Paola A., et al.
Publicado: (2021)

Creation of a Robotically Assisted Terminal Jejunogastrostomy Is Safe and Effective in Regaining Antegrade Enteral Bile Duct Access After Live Donor Liver Transplant With Roux Limb
por: Rofaiel, George, et al.
Publicado: (2019)

Improving Safety in Living Liver Donation: Lessons From Intraoperative Adverse Events in 438 Donors Undergoing a Left Liver Resection
por: Bonaccorsi-Riani, Eliano, et al.
Publicado: (2023)

Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience
por: Benkö, Tamas, et al.
Publicado: (2017)

Outcomes in Adult Liver Transplant Recipients Using Pediatric Deceased Donor Liver Grafts
por: Vargas, Paola A., et al.
Publicado: (2022)

Improved Survival With Higher-risk Donor Grafts in Liver Transplant With Acute-on-chronic Liver Failure
por: Kitajima, Toshihiro, et al.
Publicado: (2022)

Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters
por: Goussous, Naeem, et al.
Publicado: (2021)

A Clinical Tool to Guide Selection and Utilization of Marginal Donor Livers With Graft Steatosis in Liver Transplantation
por: Steggerda, Justin A., et al.
Publicado: (2022)

Donor Diabetes and Prolonged Cold Ischemia Time Synergistically Increase the Risk of Graft Failure After Liver Transplantation
por: Brüggenwirth, Isabel M.A., et al.
Publicado: (2017)

Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey
por: Akamatsu, Nobuhisa, et al.
Publicado: (2021)

Normothermic Machine Perfusion of Deceased Donor Liver Grafts Is Associated With Improved Postreperfusion Hemodynamics
por: Angelico, Roberta, et al.
Publicado: (2016)

Biliary Complications Following Adult Deceased Donor Liver Transplantation: Risk Factors and Implications at a High-volume US Center
por: Matar, Abraham J., et al.
Publicado: (2021)

The Measurement of Donor-Specific Cell-Free DNA Identifies Recipients With Biopsy-Proven Acute Rejection Requiring Treatment After Liver Transplantation
por: Goh, Su Kah, et al.
Publicado: (2019)

Early Allograft Dysfunction After Liver Transplantation With Donation After Circulatory Death and Brain Death Grafts: Does the Donor Type Matter?
por: Mazilescu, Laura Ioana, et al.
Publicado: (2021)

Belatacept Treatment of Recurrent Late-onset T Cell–mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient
por: Klintmalm, Göran B., et al.
Publicado: (2022)

A Novel Surgical Technique to Assure Donor and Recipient Safety: Pyloric to Segment 4 Arterial Reconstruction
por: Fraile, Andres, et al.
Publicado: (2020)

Retransplantation in Late Hepatic Artery Thrombosis: Graft Access and Transplant Outcome
por: Buchholz, Bettina M., et al.
Publicado: (2017)

Reexamining Risk Aversion: Willingness to Pursue and Utilize Nonideal Donor Livers Among US Donation Service Areas
por: Halpern, Samantha E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ffku7rm1pk8ljcoosjfve60kmg